5441722025-10-012025-12-315441722025-04-012025-12-315441722025-10-012025-12-31in-capmkt:OtherExpenses1Member5441722025-04-012025-12-31in-capmkt:OtherExpenses1Member5441722025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441722025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441722025-10-012025-12-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544172INDGNNOTLISTEDINE065X01017Indegene LimitedMain BoardEquity2025-04-012026-03-312026-01-292026-01-22INRMillionsQuarterlyThird quarterSingle segmentWhere financial results contain both consolidated financial results and standalone financial results of the parent, segment information is required to be presented only in the consolidated financial results. Accordingly, segment information has been presented in the consolidated financial results.2026-01-2917:30:002026-01-2918:07:00Declaration of unmodified opinionfalsefalseNo external loans and debt securities held by Company2025-10-012025-12-31UnauditedStandalone2901000000226000000312700000000020190000001800000095000000505000000263700000049000000004900000001290000001300000014200000003480000000000348000000500000035300000048000000021.451.44001.451.44Earnings per share is not annualised for quarter and nine months ended <BR> <BR> Notes to the Statement of Standalone Financial Results for quarter and nine months ended 31 December 2025 <BR> All amounts in INR millions except share data and where otherwise stated <BR> <BR> 1 The above Standalone Financial Results of the Indegene Limited the Company have been prepared in accordance with Indian Accounting Standards Ind AS 34 Interim Financial Reporting recognition and measurement principles of Indian Accounting Standards Ind AS prescribed under Section 133 of the Companies Act 2013 as amended read with the relevant rules issued there under and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 the Regulations Due to rounding off the numbers presented throughout may not add up precisely to the totals Caret symbol in the financial information denote amounts less than INR 5 lakhs <BR> <BR> 2 The above Standalone Financial Results have been reviewed by the Audit Committee meeting held on 28 January 2026 and approved by the Board of Directors at its meeting held on 29 January 2026 The statutory auditors have performed a limited review of the Standalone Financial Results for the quarter and nine months ended 31 December 2025 and have issued an unmodified review report on the same <BR> <BR> 3 The Standalone Financial Results for the quarter and nine months ended 31 December 2025 are available on the National Stock Exchange of India Limited URL www nseindia com the BSE Limited website URL www bseindia com and on the Companys website URL www indegene com investor relations <BR> <BR> 4 The Company publishes this Standalone Financial Results along with the Consolidated Financial Results In accordance with Ind AS 108 Operating Segments the Company has disclosed the segment information in the Consolidated Financial Results <BR> <BR> 5 On 21 November 2025 the Government of India notified provisions of the Code on Wages 2019 the Industrial Relations Code 2020 the Code on Social Security 2020 and the Occupational Safety Health and Working Conditions Code 2020 Labour Codes which consolidate twenty nine existing labour laws into a unified framework governing employee benefits during employment and post employment The Labour Codes amongst <BR> other things introduces changes including a uniform definition of wages and enhanced benefits relating to leave The Company based on the evaluation of the labour code has concluded that these changes do not have any material impact on the Company s Financial Results In case of any further clarification from the Government on other aspects of the New Labour Codes the Company will evaluate and account for differential impact if any in subsequent periods on the Standalone Financial Results2025-04-012025-12-31UnauditedStandalone852400000072200000092460000000005818000000550000002540000001256000000738300000018630000000186300000044800000017000000465000000013980000000000139800000031000000142900000048000000025.835.79005.835.79Other expenses505000000Other expenses1256000000Remeasurement of defined benefit obligation60000006000000Remeasurement of defined benefit obligation420000004200000010000001100000000500000031000000UnauditedtrueDeloitte Haskins & Sellstrue2028-04-30